Variant report
Variant | esv3363955 |
---|---|
Chromosome Location | chr2:78948346-78969471 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201222856 | chr2:78948370-78948371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565790859 | chr2:78948372-78948373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576897416 | chr2:78948401-78948402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192032960 | chr2:78948447-78948448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs184160838 | chr2:78948471-78948472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537327283 | chr2:78948497-78948498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557597105 | chr2:78948530-78948531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577386162 | chr2:78948532-78948533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144618408 | chr2:78948541-78948542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs74533383 | chr2:78948569-78948570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188707895 | chr2:78948601-78948602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541077708 | chr2:78948634-78948635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78660898 | chr2:78948642-78948643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530038512 | chr2:78948650-78948651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs80230111 | chr2:78948707-78948708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75916070 | chr2:78948708-78948709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543370161 | chr2:78948713-78948714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76813764 | chr2:78948729-78948730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532180660 | chr2:78948730-78948731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112706447 | chr2:78948766-78948767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138566429 | chr2:78948779-78948780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182292349 | chr2:78961622-78961623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574389464 | chr2:78961668-78961669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144303229 | chr2:78961682-78961683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556725239 | chr2:78961703-78961704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187188937 | chr2:78961714-78961715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191647540 | chr2:78961758-78961759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs35184533 | chr2:78961761-78961762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147808550 | chr2:78961764-78961765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546489166 | chr2:78961797-78961798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs75069322 | chr2:78961882-78961883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542239847 | chr2:78961921-78961922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562393759 | chr2:78961931-78961932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576816868 | chr2:78961949-78961950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535220613 | chr2:78961955-78961956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs72812607 | chr2:78961967-78961968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551259300 | chr2:78962015-78962016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571046536 | chr2:78962038-78962039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs142521028 | chr2:78962168-78962169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184595645 | chr2:78962192-78962193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144850358 | chr2:78962202-78962203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534364804 | chr2:78962247-78962248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188265932 | chr2:78962298-78962299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs17645640 | chr2:78962348-78962349 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs536965913 | chr2:78962350-78962351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530327369 | chr2:78962359-78962360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556949837 | chr2:78962360-78962361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs55869585 | chr2:78962366-78962367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs545667711 | chr2:78962405-78962406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553476538 | chr2:78962412-78962413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:78946800-78948600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr2:78948600-78948800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr2:78961600-78962600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |